Press "Enter" to skip to content

Monitoring of ctDNA in Patients With Bladder Cancer Has Potential to Assist Therapy Selection – Targeted Oncology

admin 0

Monitoring of ctDNA in Patients With Bladder Cancer Has Potential to Assist Therapy Selection  Targeted Oncology

By testing circulating tumor DNA (ctDNA) at critical time points throughout neoadjuvant chemotherapy and cystectomy, clinicians may be able to better predict …

“bladder cancer” – Google News

(Visited 4 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *